Annual Operating Expenses
$101.06 M
+$55.55 M+122.05%
December 31, 2022
Summary
- As of February 9, 2025, PNT annual total operating expenses is $101.06 million, with the most recent change of +$55.55 million (+122.05%) on December 31, 2022.
- During the last 3 years, PNT annual operating expenses has risen by +$87.94 million (+670.56%).
Performance
PNT Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Operating Expenses
$32.42 M
-$3.95 M-10.86%
September 30, 2023
Summary
- As of February 9, 2025, PNT quarterly total operating expenses is $32.42 million, with the most recent change of -$3.95 million (-10.86%) on September 30, 2023.
- Over the past year, PNT quarterly operating expenses has increased by +$7.78 million (+31.58%).
Performance
PNT Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
PNT Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +122.0% | +31.6% |
| 3 y3 years | +670.6% | +953.8% |
| 5 y5 years | +670.6% | +904.6% |
PNT Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -55.0% | -10.9% | -56.5% |
| 5 y | 5-year | at high | -87.0% | -10.9% | -90.5% |
| alltime | all time | at high | -87.0% | -10.9% | -90.5% |
POINT Biopharma Global Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $32.42 M(-10.9%) |
| Jun 2023 | - | $36.37 M(+13.9%) |
| Mar 2023 | - | $31.92 M(-9.4%) |
| Dec 2022 | $101.06 M(+122.0%) | $35.22 M(+42.9%) |
| Sep 2022 | - | $24.64 M(-1.0%) |
| Jun 2022 | - | $24.89 M(+52.6%) |
| Mar 2022 | - | $16.31 M(+15.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $45.51 M(+247.0%) | $14.10 M(-17.2%) |
| Sep 2021 | - | $17.03 M(+96.9%) |
| Jun 2021 | - | $8.65 M(+50.9%) |
| Mar 2021 | - | $5.73 M(+6.1%) |
| Dec 2020 | $13.11 M | $5.40 M(+75.6%) |
| Sep 2020 | - | $3.08 M(-4.7%) |
| Jun 2020 | - | $3.23 M |
FAQ
- What is POINT Biopharma Global annual total operating expenses?
- What is the all time high annual operating expenses for POINT Biopharma Global?
- What is POINT Biopharma Global annual operating expenses year-on-year change?
- What is POINT Biopharma Global quarterly total operating expenses?
- What is the all time high quarterly operating expenses for POINT Biopharma Global?
- What is POINT Biopharma Global quarterly operating expenses year-on-year change?
What is POINT Biopharma Global annual total operating expenses?
The current annual operating expenses of PNT is $101.06 M
What is the all time high annual operating expenses for POINT Biopharma Global?
POINT Biopharma Global all-time high annual total operating expenses is $101.06 M
What is POINT Biopharma Global annual operating expenses year-on-year change?
Over the past year, PNT annual total operating expenses has changed by +$55.55 M (+122.05%)
What is POINT Biopharma Global quarterly total operating expenses?
The current quarterly operating expenses of PNT is $32.42 M
What is the all time high quarterly operating expenses for POINT Biopharma Global?
POINT Biopharma Global all-time high quarterly total operating expenses is $36.37 M
What is POINT Biopharma Global quarterly operating expenses year-on-year change?
Over the past year, PNT quarterly total operating expenses has changed by +$7.78 M (+31.58%)